Vertex Pharma's most recent trend suggests a bearish bias. One trading opportunity on Vertex Pharma is a Bear Call Spread using a strike $80.00 short call and a strike $85.00 long call offers a potential 17.65% return on risk over the next 11 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $80.00 by expiration. The full premium credit of $0.75 would be kept by the premium seller. The risk of $4.25 would be incurred if the stock rose above the $85.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Vertex Pharma is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Vertex Pharma is bearish.
The RSI indicator is at 36.55 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Vertex Pharma
Seven takeaways from Tony Coles' closing comments at MassBio's annual meeting
Mon, 04 Apr 2016 11:00:10 GMT
The Secret’s Out: These Biotech Marvels Have Fallen Too Far
Sat, 02 Apr 2016 18:03:42 GMT
7 big stocks miss out badly on this year's rally
Fri, 01 Apr 2016 19:37:40 GMT
We See Value in Vertex
Fri, 01 Apr 2016 11:00:00 GMT
Worst Stocks Of The First Quarter
Thu, 31 Mar 2016 17:27:13 GMT
Also on Market Tamer…
Follow Us on Facebook